Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumab

BACKGROUND: Anemia is common in patients with rheumatoid arthritis (RA). Higher hemoglobin (Hb) levels may be associated with better clinical outcomes and patient-reported outcomes (PROs). To assess this hypothesis, we conducted two post hoc analyses in three sarilumab phase III studies: TARGET, MOB...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubbert-Roth, Andrea, Furst, Daniel E., Fiore, Stefano, Praestgaard, Amy, Bykerk, Vivian, Bingham, Clifton O., Charles-Schoeman, Christina, Burmester, Gerd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404615/
https://www.ncbi.nlm.nih.gov/pubmed/36008838
http://dx.doi.org/10.1186/s13075-022-02891-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404615/
https://www.ncbi.nlm.nih.gov/pubmed/36008838
http://dx.doi.org/10.1186/s13075-022-02891-x

Ejemplares similares